Metraipolis › archive › dc_27784ca1c5ec

Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance — Europe PMC PMID:42512253

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512253
DOI
10.3390/cancers18142187
License (as archived)
solo-consultazione
Archived
2026-10-18T10:16:06.762Z
SHA-256 of the archived text
ba7b0eb77b356e313bc05d3af4ddd201c4f85846e5cc20574cc2a4ce276358a2
Stable URL of this page
https://metraipolis.com/documento/dc_27784ca1c5ec

How to cite

Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance — Europe PMC PMID:42512253 — Europe PMC (en), https://europepmc.org/article/MED/42512253 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_27784ca1c5ec (Metraipolis archive dc_27784ca1c5ec, sha256 ba7b0eb77b356e313bc05d3af4ddd201c4f85846e5cc20574cc2a4ce276358a2)
BibTeX
@misc{dc27784ca1c5ec,
  title = {Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance — Europe PMC PMID:42512253},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512253},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_27784ca1c5ec; sha256 ba7b0eb77b356e313bc05d3af4ddd201c4f85846e5cc20574cc2a4ce276358a2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512253. Agents can read the archived copy with the MCP tool read_document.